HOME >> MEDICINE >> NEWS
Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone

Combining pre-operative chemotherapy and surgery increases the average chance of survival at five years by approximately 6% compared with surgery alone.

This conclusion was drawn by a team of Cochrane Researchers from the MRC Clinical Trials Unit in London after they identified 12 eligible randomised controlled trials. Data from seven of these trials were available from trial reports and were combined in a meta-analysis. The seven trials involved a total of 988 patients.

This is currently the best estimate of the effectiveness of this therapy, but is based on a relatively small number of trials and patients, says lead researcher Sarah Burdett.

There was, however, insufficient data to break the patients down into sub-groups and see whether the effectiveness varies for different types of patients or stages of the disease.

This research is important because around the world more than a million new cases of lung cancer are diagnosed each year, around 80% of which are non-small cell lung cancer. In addition, many patients are only diagnosed after the disease has progressed, so survival rates across all stages of disease tend to be fairly low at around 14%, with only a quarter of patients being suitable for surgery.

The Cochrane Systematic Review found that using chemotherapy before surgery can reduce the size of tumours making the surgery simpler, and increasing the number of patients who may be candidates for surgery. The worry is, however, that having a course of chemotherapy delays the operation, and could therefore leave patients at risk of allowing the tumour to spread.

The data suggest that the benefits of the chemotherapy outweigh the risks associated with the delay, says Burdett

A project to collect complete data on all patients included in all trials is ongoing and will be able to fully assess the value of this treatment.


'"/>

Contact: Jennifer Beal
jbeal@wiley.co.uk
44-012-437-70633
John Wiley & Sons, Inc.
17-Jul-2007


Page: 1

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. Stomach cancer rate set to fall further 25 percent over next decade
4. MRI finds breast cancer before it becomes dangerous
5. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
6. New cause of tamoxifen resistance in breast cancer cells discovered at Lombardi
7. Pathway links inflammation, angiogenesis and breast cancer
8. Using MRI for diagnosis could help prevent breast cancer progression
9. Electric fields have potential as a cancer treatment
10. Shining light on pancreatic cancer
11. Method shows promise for early detection of pancreatic cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/11/2019)... ... November 11, 2019 , ... ... primary care and occupational medicine, is expanding its long-term partnership with 919 ... engage franchise candidates. With more than 200 locations across the country, American Family ...
(Date:11/11/2019)... (PRWEB) , ... November 11, 2019 , ... Dr. John ... Department of Health and Human Services’ (HHS) Pain Management Best Practices Task Force (Pain ... , This meeting was in follow up to the HHS Pain Task Force’s final ...
(Date:11/9/2019)... ... November 08, 2019 , ... The Women’s Dermatologic Society (WDS) announced ... concerns. The WDS Board of Directors appointed Molly Hinshaw, MD to fill the remainder ... March 2019-March 2020 term and will be presented to the membership as the 2020-2021 ...
(Date:11/9/2019)... ... November 08, 2019 , ... Mount Sinai Medical-Legal Partnership (MSMLP), ... two initiatives that provide free special education law and advocacy assistance to families and ... Sinai that also honored the work of contributions of Blaine (“Fin”) Fogg, who was ...
(Date:11/7/2019)... ... ... Atlantic Ultraviolet Corporation makes it their business to fight the flu. The first ... season starts in October until March, Atlantic Ultraviolet makes it a point to host ... get their shot. , Ann Wysocki, COO of Atlantic Ultraviolet Corporation® says, “Atlantic Ultraviolet ...
Breaking Medicine News(10 mins):
(Date:11/11/2019)... ... 10, 2019 , ... A gifted actor and generous philanthropist, Laurence Fishburne, will ... an episode of "Behind The Scenes." The growth of health management tools in health ... staff. This segment will focus on which tools are the most successful in allowing ...
(Date:11/9/2019)... ... November 08, 2019 , ... As part ... sets aside a day to help raise awareness and improve diagnosis of a ... Unlike some forms of PH, CTEPH has several treatment options, including a potentially ...
(Date:11/9/2019)... ... November 09, 2019 , ... “Strong, silent” types ... hallmark of much-loved, fictional British characters, like James Bond and Sherlock Holmes, and, ... admire about calm stoicism, even in the most perilous and dire of situations? ...
Breaking Medicine Technology:
Cached News: